34 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Protalix Competitors or Alternatives

Protalix's top competitors include Dyadic, iBio and Medicago.

Unlock 11 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Protalix's company profile

Dror Bashan

President & CEO

87/100
200
$121.8M
$53.4M
  • $121.8M
    $53.4M
  • 200
    $121.8M
  • $53.4M
  • 87/100
  • 200
  • $121.8M
  • $53.4M
View ProfileView
1
Protalix's Competitor - Dyadic logo

Mark A. Emalfarb

President & CEO

69/100
7
$9.6M
$3.5M
  • $9.6M
    $3.5M
  • 7
    $9.6M
  • $3.5M
  • 69/100
  • 7
  • $9.6M
  • $3.5M
View ProfileView
2
Protalix's Competitor - iBio logo

Martin Brenner

CEO

82/100
100
$31.4M
$ < 1M
  • $31.4M
    $ < 1M
  • 100
    $31.4M
  • $ < 1M
  • 82/100
  • 100
  • $31.4M
  • $ < 1M
View ProfileView
3
Protalix's Competitor - Medicago logo

Toshifumi Tada

President & CEO

82/100
250 - 500
$23.4M
$25M - 100M
  • $23.4M
    $25M - 100M
  • 250 - 500
    $23.4M
  • $25M - 100M
  • 82/100
  • 250 - 500
  • $23.4M
  • $25M - 100M
View ProfileView
4
Protalix's Competitor - Crucell logo

CEO

- -
1,000 - 5,000
- -
$100M - 500M
  • - -
    $100M - 500M
  • 1,000 - 5,000
    - -
  • $100M - 500M
  • - -
  • 1,000 - 5,000
  • - -
  • $100M - 500M
View ProfileView
5
Protalix's Competitor - Icosavax logo

Adam K. Simpson

President & CEO

88/100
30
$405.3M
$ < 1M
  • $405.3M
    $ < 1M
  • 30
    $405.3M
  • $ < 1M
  • 88/100
  • 30
  • $405.3M
  • $ < 1M
View ProfileView
Protalix's top 14 competitors are Dyadic, iBio, Medicago, Greenovation, Crucell, Icosavax, MNPHARM, KBI, Tedor, Alvotech, Janssen Pharmaceuticals, Batavia Biosciences, Phytonbiotech and Valerius. Together they have raised over 2.4B between their estimated 4.7K employees. Protalix has 200 employees and is ranked 5th among it's top 10 competitors. The top 10 competitors average 326.

Protalix VS Dyadic

Dyadic is perceived as one of Protalix's biggest rivals. Dyadic was founded in 1979 in Jupiter, Florida. Dyadic is in the Biotechnology field. Dyadic generates $49.9M less revenue than Protalix.

Protalix VS iBio

iBio is Protalix's #2 rival. iBio is a Public company that was founded in 2008 in Bryan, Texas. iBio competes in the Biotechnology field. Compared to Protalix, iBio has 100 fewer employees.

Protalix VS Medicago

Medicago is one of Protalix's top competitors. Medicago's headquarters is in Quebec, Quebec, and was founded in 1999. Like Protalix, Medicago also operates in the Biotechnology industry. Medicago generates 168% of Protalix's revenue.

Looking for similar companies to Protalix?

Similar Companies

Companies in Hackensack with employees in 100-250 range

See 36 companies 
Biotechnology companies in New Jersey

See 414 companies 
Companies in Hackensack with revenue in $25-100M range

See 60 companies 
Biotechnology companies with revenue in $25-100M range

See 854 companies 
Biotechnology companies in New York Metropolitan Area

See 859 companies 
Pharmaceuticals & Biotechnology companies in New Jersey

See 1,085 companies 
Biotechnology companies with employees in 100-250 range

See 1,110 companies 
Pharmaceuticals & Biotechnology companies with revenue in $25-100M range

See 1,457 companies 
Pharmaceuticals & Biotechnology companies in New York Metropolitan Area

See 1,762 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Protalix and Protalix's Competitors

April 10, 2025Endpoints News
With US tariffs on pharmaceuticals likely to come "very soon," another of the world's largest drugmakers is announcing plans to beef up their American ...
April 10, 2025Pharmabiz
Bristol Myers Squibb, announced that the US Food and Drug Administration (FDA) approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first─line tre...
April 9, 2025StreetInsider
Continues to Strengthen Its Pandemic Preparedness and Biodefense Vaccine Portfolio ATLANTA, GA - April 9, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc.......
April 10, 2025Pharmaceutical Processing World
Novartis announced today that it plans to invest $23 billion over five years to expand its U.S.-based infrastructure. The company said its investment a...
April 9, 2025BioSpace
The FDA approved the use of Opdivo with Yervoy in front-line colorectal cancer, while a Manhattan court junked a class action complaint over the blood ...
April 10, 2025Openpr
Valued at USD 376.8 Mn in 2025 and is expected to reach USD 617.0 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032...
April 9, 2025Openpr
The Diabetic Retinopathy Market is estimated to be valued at USD 9.91 Bn in 2025 and is expected to reach USD 15.40 Bn by 2032, exhibiting a compound a...

Frequently Asked Questions about Protalix

  1. Who are Protalix's top competitors?

    Protalix's top 3 competitors are Dyadic, iBio, Medicago.

  2. Who is similar to Protalix?

    Dyadic is the most similar to Protalix. iBio and Medicago are also similar to Protalix.

  1. Are Protalix and Dyadic competitors?

    Yes, Dyadic is one of Protalix’s top competitors.